Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.

Autor: Linhares AC (AUTHOR), Velázquez FR (AUTHOR), Pérez-Schael I (AUTHOR), Sáez-Llorens X (AUTHOR), Abate H (AUTHOR), Espinoza F (AUTHOR), López P (AUTHOR), Macías-Parra M (AUTHOR), Ortega-Barría E (AUTHOR), Rivera-Medina DM (AUTHOR), Rivera L (AUTHOR), Pavía-Ruz N (AUTHOR), Nuñez E (AUTHOR), Damaso S (AUTHOR), Ruiz-Palacios GM (AUTHOR), De Vos B (AUTHOR), O'Ryan M (AUTHOR), Gillard P (AUTHOR), Bouckenooghe A (AUTHOR), Human Rotavirus Vaccine Study Group (CORPORATE AUTHOR)

Publikováno v: Lancet. 4/5/2008, Vol. 371 Issue 9619, p1181-1189. 9p.